Epigallocatechin-3-O -gallate-loaded poly(lactic-co-glycolic acid) fibrous sheets as anti-adhesion barriers

Journal of Biomedical Nanotechnology

Volumn 11, Issue 8, 2014, Pages 1461-1471

  Lee, Jong Ho ^a   Shin, Yong Cheol ^a   Yang, Won Jun ^a   Park, Jong Chul ^b   Hyon, Suong Hyu ^c   Han, Dong Wook ^a  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Electrospinning; Epigallocatechin 3 O Gallate; Fibrous sheet; Poly(Lactic Co Glycolic acid); Tissue Adhesion barrier.

Indexed keywords

ADHESION; ELECTROSPINNING; SURGERY;

CHEMICAL INTERACTIONS; CONTROLLED DIFFUSION; FIBROUS SHEET; GALLATE; INFLAMMATORY RESPONSE; PHARMACOLOGICAL ACTIVITY; POLY LACTIC-CO-GLYCOLIC ACID; TISSUE ADHESION;

TISSUE;

EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NANOFIBER; POLYGLACTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CATECHIN; LACTIC ACID; NANOCAPSULE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRADATION; DISEASE SEVERITY; ELECTROSPINNING; FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYDROPHILICITY; INFLAMMATION; INFLAMMATORY CELL; J774A.1 CELL; L929 CELL LINE; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PERITONEUM ADHESION; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; RAT; SUSTAINED DRUG RELEASE; TISSUE ADHESION; TISSUE REACTION; ADSORPTION; ANALOGS AND DERIVATIVES; ANIMAL; BANDAGE; CHEMISTRY; MALE; MATERIALS TESTING; PATHOLOGY; SPRAGUE DAWLEY RAT; SURFACE PROPERTY; TISSUE ADHESIONS; TREATMENT OUTCOME; ULTRASTRUCTURE;

ADSORPTION; ANIMALS; ANTIOXIDANTS; BANDAGES; CATECHIN; LACTIC ACID; MALE; MATERIALS TESTING; NANOCAPSULES; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; TISSUE ADHESIONS; TREATMENT OUTCOME;

EID: 84919916262     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2080     Document Type: Article

References (54)

1. D. Brüggmann, G. Tchartchian, M. Wallwiener, K. Münstedt, H. R. Tinneberg, and A. Hackethal, Intra-abdominal adhesions: Definition, origin, significance in surgical practice, and treatment options. Deutsches Ärzteblatt International 107, 769 (2010).
2. G. S. diZerega and J. D. Campeau, Peritoneal repair and postsurgical adhesion formation. Human Reproduction Update 7, 547 Delivered by Publishing Technology IP: 203.56.241.128 On: Wed,Copyright: American (2001).
3. Y. C. Cheong, S. M. Laird, T. C. Li, J. B. Shelton, W. L. Ledger, and I. D. Cooke, Peritoneal healing and adhesion formation/reformation. Human Reproduction Update 7, 556 (2001).
4. Z. Alpay, G. M. Saed, and M. P. Diamond, Postoperative adhesions: From formation to prevention. Seminars in Reproductive Medicine 26, 313 (2008).
5. R. M. Kamel, Prevention of postoperative peritoneal adhesions. European Journal of Obstetrics and Gynecology and Reproductive Biology 150, 111 (2010).
6. T. Liakakos, N. Thomakos, P. M. Fine, C. Dervenis, and R. L. Young, Peritoneal adhesions: Etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Digestive Surgery 18, 260 (2001).
7. H. Van Goor, Consequences and complications of peritoneal adhesions. Colorectal Disease 9, 25 (2007).
8. A. Hirschelmann, G. Tchartchian, M. Wallwiener, A. Hackethal, and R. L. De Wilde, A review of the problematic adhesion prophylaxis in gynaecological surgery. Archives of Gynecology and Obstetrics 285, 1089 (2012).
9. M. Metwally, A. Watson, R. Lilford, and P. Vandekerckhove, Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews 2, CD001298 (2006).
10. G. Ahmad, J. M. Duffy, C. Farquhar, A. Vail, P. Vandekerckhove, A. Watson, and D. Wiseman, Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews 2, CD000475 (2008).
11. A. H. Maciver, M. McCall, and A. M. J. Shapiro, Intra-abdominal adhesions: Cellular mechanisms and strategies for prevention. International Journal of Surgery 9, 589 (2011).
12. B. C. Ward and A. Panitch, Abdominal adhesions: Current and novel therapies. Journal of Surgical Research 165, 91 (2011).
13. X. Zong, S. Li, E. Chen, B. Garlick, K. S. Kim, D. Fang, J. Chiu, T. Zimmerman, C. Brathwaite, B. S. Hsiao, and B. Chu, Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Annals of Surgery 240, 910 (2004).
14. J. H. Lee, A. K. Go, S. H. Oh, K. E. Lee, and S. H. Yuk, Tissue anti-adhesion potential of ibuprofen-loaded PLLA-PEG diblock copolymer films. Biomaterials 26, 671 (2005).
15. Y. Hong, K. Fujimoto, R. Hashizume, J. Guan, J. J. Stankus, K. Tobita, and W. R. Wagner, Generating elastic, biodegradable polyurethane/poly(lactide-co-glycolide) fibrous sheets with controlled antibiotic release via two-stream electrospinning. Biomacromolecules 9, 1200 (2008).
16. H. H. Cho, D. W. Han, K. Matsumura, S. Tsutsumi, and S. H. Hyon, The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-ε -caprolactone) as stent-coating materials. Biomaterials 29, 884 (2008).
17. D. W. Han, J. J. Lee, D. Y. Jung, J. C. Park, and S. H. Hyon, Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations. Biomedical Materials 4, 044104 (2009).
18. H. J. Hwang, M. S. An, T. K. Ha, K. H. Kim, T. H. Kim, C. S. Choi, K. H. Hong, S. J. Jung, S. H. Kim, K. H. Rho, and K. B. Bae, All the commercially available adhesion barriers have the same effect on adhesion prophylaxis?; A comparison of barrier agents using a newly developed, severe intra-abdominal adhesion model. International Journal of Colorectal Disease 28, 1117 (2013).
19. R. E. Leach, J. W. Burns, E. J. Dawe, M. D. SmithBarbour, and M. P. Diamond, Reduction of postsurgical adhesion formation in the rabbit uterine horn model with use of hyaluronate/carboxymethylcellulose gel. Fertility and Sterility 69, 415 (1998).
20. J. J. Knightly, D. Agostino, and E. E. Cliffton, The effect of fibrinolysin and heparin on the formation of peritoneal adhesions. Surgery 52, 250 (1962).
21. L. Jin, T. Wang, M. L. Zhu, M. K. Leach, Y. I. Naim, J. M. Corey, Z. Q. Feng, and Q. Jiang, Electrospun fibers and tissue engineering. Journal of Biomedical Nanotechnology 8, 1 (2012).
22. Y. Ouyang, C. Huang, Y. Zhu, C. Fan, and Q. Ke, Fabrication of seamless electrospun collagen/PLGA conduits whose walls comprise highly longitudinal aligned nanofibers for nerve regeneration. Journal of Biomedical Nanotechnology 9, 931 (2013).
23. S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson, The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-A review. Int. J. Phytorem. 415, 34 (2011).
24. D. G. Yu, L. M. Zhu, K. White, and C. Branford-White, Electrospun nanofiber-based drug delivery systems. Health 1, 67, (2009).
25. J. Xie and C. H. Wang, Electrospun micro-and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm. Res. 23, 1817 (2006).
26. X. L. Xu, L. X. Yang, X. Y. Xu, X. Wang, X. S. Chen, Q. Z. Liang, J. Zeng, and X. B. Jing, Ultrafine medicated fibers electrospun from W/O emulsions. J. Controlled Release 108, 33 (2005).
27. N. Pirooznia, S. Hasannia, A. S. Lotfi, and M. Ghanei, Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: In vitro characterization as an effective aerosol formulation in pulmonary diseases. Journal of Nanobiotechnology 10, 20 (2012).
28. H. Tachibana, K. Koga, Y. Fujimura, and K. Yamada, A receptor for green tea polyphenol EGCG. Nature Structural and Molecular Biology 11, 380 (2004).
29. D. W. Han, K. Matsumura, B. Kim, and S. H. Hyon, Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-Ogallate in L-929 cells. Bioorganic Medicinal Chemistry 16, 9652 (2008).
30. J. Y. Bae, J. Kanamune, D. W. Han, K. Matsumura, and S. H. Hyon, Reversible regulation of cell cycle-related genes by epigallocatechin gallate for hibernation of neonatal human tarsal fibroblasts. Cell Transplantation 18, 459 (2009).
31. D. W. Han, M. H. Lee, H. H. Kim, S. H. Hyon, and J. C. Park, Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor- B in human dermal fibroblasts. Acta Pharmacologica Sinica 32, 637 (2011).
32. M. H. Lee, D. W. Han, S. H. Hyon, and J. C. Park, Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O -gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor- B. Apoptosis 16, 75 (2011).
33. M. F. Neurath and S. Finotto, IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine and Growth Factor Reviews 22, 83 (2011).
34. W. M. Chu, Tumor necrosis factor. Cancer Letters 328, 222 (2013).
35. R. Nicolete, D. F. dos Santos, and L. H. Faccioli, The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. International Immunopharmacology 11, 1557 (2011).
36. M. S. Kim, H. H. Ahn, Y. N. Shin, M. H. Cho, G. Khang, and H. B. Lee, An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosabased scaffolds. Biomaterials 28, 5137 (2007).
37. S. Jilek, E. Walter, H. P. Merkle, and B. Corthesy, Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres. Journal of Allergy and Clinical Immunology 114, 943 (2004).
38. H. Y. Shin, S. H. Kim, H. J. Jeong, S. Y. Kim, T. Y. Shin, J. Y. Um, S. H. Hong, and H. M. Kim, Epigallocatechin-3-gallate inhibits secretion of TNF-α, IL-6 and IL-8 through the attenuation of ERK and NF- B in HMC-1 cells. International Archives of Allergy and Immunology 142, 335 (2007).
39. Y. Hosokawa, I. Hosokawa, K. Ozaki, T. Nakanishi, H. Nakae, and T. Matsuo, Tea polyphenols inhibit IL-6 production in tumor necrosis factor superfamily 14-stimulated human gingival fibroblasts. Molecular Nutrition and Food Research 54, S151 (2010).
40. D. E. Beck, Z. Cohen, J. W. Fleshman, H. S. Kaufman, H. van Goor, and B. G. Wolff, A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Diseases of the Colon and Rectum 46, 1310 (2003).
41. Q. Zeng, Z. Yu, J. You, and Q. Zhang, Efficacy and safety of Seprafilm for preventing postoperative abdominal adhesion: Systematic review and meta-analysis. World Journal of Surgery 31, 2125 Delivered by Publishing Technology IP: 203.56.241.128 On: Wed,Copyright: American (2007).
42. J. K. Jackson, K. C. Skinner, L. Burgess, T. Sun, W. L. Hunter, and H. M. Burt, Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm. Res. 19, 411 (2002).
43. A. H. Maciver, M. D. McCall, R. L. Edgar, A. L. Thiesen, D. L. Bigam, T. A. Churchill, and A. M. Shapiro, Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model. Surgery 150, 907 (2011).
44. T. Iwamoto, Clinical application of drug delivery systems in cancer chemotherapy: Review of the efficacy and side effects of approved drugs. Biol. Pharm. Bull. 36, 715 (2013).
45. P. T. Pham, P. C. Pham, G. M. Danovitch, D. J. Ross, H. A. Gritsch, E. A. Kendrick, J. Singer, T. Shah, and A. H. Wilkinson, Sirolimus-associated pulmonary toxicity. Transplantation 77, 1215 (2004).
46. C. D. Wu and G. X. Wei, Tea as a functional food for oral health. Nutrition 18, 443 (2002).
47. P. C. Chan, Y. Ramot, D. E. Malarkey, P. Blackshear, G. E. Kissling, G. Travlos, and A. Nyska, Fourteen-week toxicity study of green tea extract in rats and mice. Toxicologic Pathology 38, 1070 (2010).
48. J. H. Kim, J. H. Lee, J. H. Yoon, J. H. Chang, J. H. Bae, and K. S. Kim, Antiadhesive effect of the mixed solution of sodium hyaluronate and sodium carboxymethylcellulose after endoscopic sinus surgery. American Journal of Rhinology 21, 95 (2007).
49. J. S. Park, S. J. Cha, B. G. Kim, Y. S. Choi, G. Y. Kwon, H. Kang, and S. S. An, An assessment of the effects of a hyaluronan-based solution on reduction of postsurgical adhesion formation in rats: A comparative study of hyaluronan-based solution and two film barriers. Journal of Surgical Research 168, 49 (2011).
50. B. W. Fenton and J. Fanning, Laparoscopic application of hyaluronate/carboxymethylcellulose slurry: An adhesion barrier in a slurry formulation goes where the available sheets cannot. American Journal of Obstetrics and Gynecology 199, 325e1 (2008).
51. J. S. Park, J. H. Lee, C. S. Han, D. W. Chung, and G. Y. Kim, Effect of hyaluronic acid-carboxymethylcellulose solution on perineural scar formation after sciatic nerve repair in rats. Clinics in Orthopedic Surgery 3, 315 (2011).
52. T. K. Rajab, M. Wallwiener, C. Planck, C. Brochhausen, B. Kraemer, and C. W. Wallwiener, A direct comparison of seprafilm, adept, intercoat, and spraygel for adhesion prophylaxis. Journal of Surgical Research 161, 246 (2010).
53. Y. Hirasaki, M. Fukunaga, A. Kidokoro, A. Hashimoto, T. Nakamura, H. Tsujimoto, and A. Hagiwara, Development of a novel antiadhesive material, alginate flakes, ex vivo and in vivo. Surgery Today 41, 970 (2011).
54. P. Dinarvand, S. M. Hashemi, E. Seyedjafari, I. Shabani, A. Mohammadi-Sangcheshmeh, S. Farhadian, and M. Soleimani, Function of poly(lactic-co-glycolic acid) nanofiber in reduction of adhesion bands. Journal of Surgical Research 172, 1 (2012).